Indication
Neonatal bronchopulmonary dysplasia
Neonatal bronchopulmonary dysplasia is a serious chronic respiratory disease that primarily develops in preterm infants, particularly those born at very low birth weight who require prolonged mechanical ventilation and supplemental oxygen therapy for infant respiratory distress syndrome. Read more about Neonatal bronchopulmonary dysplasia
10 drugs 9 manufacturers
Drugs that treat it
Common Neonatal bronchopulmonary dysplasia therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonNeonatal bronchopulmonary dysplasia is a serious chronic respiratory disease that primarily develops in preterm infants, particularly those born at very low birth weight who require prolonged mechanical ventilation and supplemental oxygen therapy for infant respiratory distress syndrome.
It is pathophysiologically characterized by arrested lung development, resulting in alveolar simplification, dysmorphic microvasculature, and variable airway inflammation and fibrosis triggered by barotrauma, hyperoxia, and inflammatory injury to the immature pulmonary parenchyma.
Clinically, affected neonates demonstrate persistent oxygen dependency beyond 28 days of life or at 36 weeks postmenstrual age, often accompanied by tachypnea, retractions, wheezing, and impaired gas exchange.
- nih.gov
Neonatal bronchopulmonary dysplasia is a serious chronic respiratory disease that primarily develops in preterm infants, particularly those born at very low birth weight who require prolonged mechanical ventilation and supplemental oxygen therapy for infant respiratory distress syndrome It is pathophysiologically characterized by arrested lung development, resulting in alveolar simplification, dysmorphic microvasculature, and variable airway inflammation and fibrosis triggered by barotrauma, hyp...
- nih.gov
Neonatal bronchopulmonary dysplasia is a serious chronic respiratory disease that primarily develops in preterm infants, particularly those born at very low birth weight who require prolonged mechanical ventilation and supplemental oxygen therapy for infant respiratory distress syndrome
- nih.gov
Neonatal bronchopulmonary dysplasia is a serious chronic respiratory disease that primarily develops in preterm infants, particularly those born at very low birth weight who require prolonged mechanical ventilation and supplemental oxygen therapy for infant respiratory distress syndrome Clinically, affected neonates demonstrate persistent oxygen dependency beyond 28 days of life or at 36 weeks postmenstrual age, often accompanied by tachypnea, retractions, wheezing, and impaired gas exchange
- nih.gov
It is pathophysiologically characterized by arrested lung development, resulting in alveolar simplification, dysmorphic microvasculature, and variable airway inflammation and fibrosis triggered by barotrauma, hyperoxia, and inflammatory injury to the immature pulmonary parenchyma
Personalize your experience
Follow Neonatal bronchopulmonary dysplasia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.